ABDA: AI can support pharmacy operations but not replace expertise
The German Federal Union of German Associations of Pharmacists (ABDA) emphasizes that while AI can assist in pharmacy workflows, final clinical decision-making must remain with professional pharmacists.
Pharmacy industry representatives in Germany are outlining a cautious approach to the integration of artificial intelligence in healthcare. According to Jan-Niklas Francke, a board member of the German Pharmacists Association (DAV), AI is viewed as a practical tool for back-office tasks and data analysis but is not considered a replacement for the professional judgment of qualified staff.
Francke distinguishes between passive usage—such as automating routine workflows—and the active use of AI in patient communication. While chatbots can efficiently parse large datasets or flag potential issues, their functionality remains tied to specific prompts and the quality of data provided by patients. Crucially, the ability to interpret these inputs and assume responsibility for medication outcomes is unique to human practitioners.
This stance highlights the limitations of current generative models in the pharmaceutical sector. ABDA maintains that while technology can enhance efficiency, the essential role of the pharmacist as the final authority on patient health and safety remains non-negotiable.